| 0 |
DRUG INEFFECTIVE |
9 |
| 1 |
FATIGUE |
9 |
| 2 |
DIZZINESS |
6 |
| 3 |
NAUSEA |
6 |
| 4 |
PERIPHERAL SWELLING |
6 |
| 5 |
PRODUCT DOSE OMISSION ISSUE |
6 |
| 6 |
SWELLING |
6 |
| 7 |
BLOOD CREATININE INCREASED |
5 |
| 8 |
OEDEMA |
5 |
| 9 |
RASH |
5 |
| 10 |
RENAL IMPAIRMENT |
5 |
| 11 |
ANAEMIA |
4 |
| 12 |
FLUID RETENTION |
4 |
| 13 |
OEDEMA PERIPHERAL |
4 |
| 14 |
PROTEINURIA |
4 |
| 15 |
PYREXIA |
4 |
| 16 |
BLOOD POTASSIUM INCREASED |
3 |
| 17 |
CONSTIPATION |
3 |
| 18 |
DECREASED APPETITE |
3 |
| 19 |
GLOMERULAR FILTRATION RATE DECREASED |
3 |
| 20 |
HEADACHE |
3 |
| 21 |
LABORATORY TEST ABNORMAL |
3 |
| 22 |
OFF LABEL USE |
3 |
| 23 |
SKIN DISCOLOURATION |
3 |
| 24 |
VOMITING |
3 |
| 25 |
WEIGHT INCREASED |
3 |
| 26 |
ABDOMINAL DISCOMFORT |
2 |
| 27 |
ABDOMINAL DISTENSION |
2 |
| 28 |
ABDOMINAL PAIN UPPER |
2 |
| 29 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
| 30 |
BLOOD PRESSURE INCREASED |
2 |
| 31 |
CONDITION AGGRAVATED |
2 |
| 32 |
COVID-19 |
2 |
| 33 |
DRUG HYPERSENSITIVITY |
2 |
| 34 |
DYSPEPSIA |
2 |
| 35 |
ERYTHEMA |
2 |
| 36 |
HAEMATURIA |
2 |
| 37 |
HYPERSENSITIVITY |
2 |
| 38 |
HYPERTENSION |
2 |
| 39 |
HYPERVOLAEMIA |
2 |
| 40 |
HYPOALBUMINAEMIA |
2 |
| 41 |
HYPONATRAEMIA |
2 |
| 42 |
HYPOTENSION |
2 |
| 43 |
IGA NEPHROPATHY |
2 |
| 44 |
INCREASED APPETITE |
2 |
| 45 |
INFLUENZA |
2 |
| 46 |
LEUKOPENIA |
2 |
| 47 |
MENSTRUATION IRREGULAR |
2 |
| 48 |
NASOPHARYNGITIS |
2 |
| 49 |
PNEUMONIA |
2 |
| 50 |
PROTEIN TOTAL ABNORMAL |
2 |
| 51 |
PRURITUS |
2 |
| 52 |
SINUSITIS |
2 |
| 53 |
SOMNOLENCE |
2 |
| 54 |
SWELLING FACE |
2 |
| 55 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
| 56 |
VERTIGO |
2 |
| 57 |
ABDOMINAL PAIN |
1 |
| 58 |
ACNE |
1 |
| 59 |
ACUTE KIDNEY INJURY |
1 |
| 60 |
ACUTE MYOCARDIAL INFARCTION |
1 |
| 61 |
AGEUSIA |
1 |
| 62 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
| 63 |
ANOSMIA |
1 |
| 64 |
ARRHYTHMIA |
1 |
| 65 |
ARTHRALGIA |
1 |
| 66 |
ASTHENIA |
1 |
| 67 |
BLOOD BILIRUBIN INCREASED |
1 |
| 68 |
BLOOD CALCIUM DECREASED |
1 |
| 69 |
BLOOD CALCIUM INCREASED |
1 |
| 70 |
BLOOD CREATINE INCREASED |
1 |
| 71 |
BLOOD GLUCOSE INCREASED |
1 |
| 72 |
BLOOD IRON INCREASED |
1 |
| 73 |
BLOOD POTASSIUM ABNORMAL |
1 |
| 74 |
BLOOD POTASSIUM DECREASED |
1 |
| 75 |
BLOOD PRESSURE ABNORMAL |
1 |
| 76 |
BLOOD SODIUM DECREASED |
1 |
| 77 |
BLOOD UREA INCREASED |
1 |
| 78 |
BLOOD URINE PRESENT |
1 |
| 79 |
BONE GRAFT |
1 |
| 80 |
CALCIUM METABOLISM DISORDER |
1 |
| 81 |
CARBON DIOXIDE DECREASED |
1 |
| 82 |
CARDIAC FAILURE |
1 |
| 83 |
CATARACT |
1 |
| 84 |
CERVICOBRACHIAL SYNDROME |
1 |
| 85 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
| 86 |
CONCUSSION |
1 |
| 87 |
CONFUSIONAL STATE |
1 |
| 88 |
COUGH |
1 |
| 89 |
CREATININE URINE DECREASED |
1 |
| 90 |
DEPRESSED MOOD |
1 |
| 91 |
DEVICE DIFFICULT TO USE |
1 |
| 92 |
DIARRHOEA |
1 |
| 93 |
DISCOMFORT |
1 |
| 94 |
DISEASE PROGRESSION |
1 |
| 95 |
DISORIENTATION |
1 |
| 96 |
DRUG INTERACTION |
1 |
| 97 |
DRUG INTOLERANCE |
1 |
| 98 |
DYSPNOEA |
1 |
| 99 |
EATING DISORDER |
1 |
| 100 |
END STAGE RENAL DISEASE |
1 |
| 101 |
EOSINOPHIL PERCENTAGE INCREASED |
1 |
| 102 |
EYE PRURITUS |
1 |
| 103 |
EYE SWELLING |
1 |
| 104 |
FACE OEDEMA |
1 |
| 105 |
FEAR OF INJECTION |
1 |
| 106 |
FEELING HOT |
1 |
| 107 |
FLANK PAIN |
1 |
| 108 |
FLUSHING |
1 |
| 109 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
1 |
| 110 |
FOOD AVERSION |
1 |
| 111 |
GAIT DISTURBANCE |
1 |
| 112 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
| 113 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
| 114 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
| 115 |
GLUCOSE URINE PRESENT |
1 |
| 116 |
HAEMATOCRIT DECREASED |
1 |
| 117 |
HAEMOGLOBIN DECREASED |
1 |
| 118 |
HEART RATE INCREASED |
1 |
| 119 |
HIGH DENSITY LIPOPROTEIN DECREASED |
1 |
| 120 |
HORDEOLUM |
1 |
| 121 |
HOSPITALISATION |
1 |
| 122 |
HYPERAESTHESIA TEETH |
1 |
| 123 |
HYPERCHLORHYDRIA |
1 |
| 124 |
HYPERTENSIVE CRISIS |
1 |
| 125 |
HYPOAESTHESIA |
1 |
| 126 |
HYPOKALAEMIA |
1 |
| 127 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
| 128 |
INCORRECT DOSE ADMINISTERED |
1 |
| 129 |
INJECTION SITE BRUISING |
1 |
| 130 |
INTENTIONAL UNDERDOSE |
1 |
| 131 |
JOINT SWELLING |
1 |
| 132 |
LACRIMATION INCREASED |
1 |
| 133 |
LACTOSE INTOLERANCE |
1 |
| 134 |
LUNG DISORDER |
1 |
| 135 |
LYMPHOPENIA |
1 |
| 136 |
MALAISE |
1 |
| 137 |
MIGRAINE |
1 |
| 138 |
MUCOSAL INFLAMMATION |
1 |
| 139 |
NEOPLASM MALIGNANT |
1 |
| 140 |
NERVOUSNESS |
1 |
| 141 |
NEUTROPENIA |
1 |
| 142 |
ORAL INTAKE REDUCED |
1 |
| 143 |
ORTHOSTATIC HYPOTENSION |
1 |
| 144 |
OXYGEN SATURATION DECREASED |
1 |
| 145 |
PAIN |
1 |
| 146 |
PAIN IN EXTREMITY |
1 |
| 147 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
| 148 |
PANIC ATTACK |
1 |
| 149 |
PERIORBITAL SWELLING |
1 |
| 150 |
PLATELET COUNT DECREASED |
1 |
| 151 |
PLATELET DISTRIBUTION WIDTH DECREASED |
1 |
| 152 |
PLATELET-LARGE CELL RATIO DECREASED |
1 |
| 153 |
PLATELETCRIT DECREASED |
1 |
| 154 |
PRESCRIBED UNDERDOSE |
1 |
| 155 |
PRODUCT ADMINISTRATION ERROR |
1 |
| 156 |
PRODUCT DELIVERY MECHANISM ISSUE |
1 |
| 157 |
PRODUCT PRESCRIBING ERROR |
1 |
| 158 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
| 159 |
PROTEIN TOTAL DECREASED |
1 |
| 160 |
PROTEIN TOTAL INCREASED |
1 |
| 161 |
PROTEIN URINE |
1 |
| 162 |
PULMONARY EMBOLISM |
1 |
| 163 |
PULMONARY HAEMORRHAGE |
1 |
| 164 |
RASH ERYTHEMATOUS |
1 |
| 165 |
RED BLOOD CELL COUNT DECREASED |
1 |
| 166 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
| 167 |
RENAL DISORDER |
1 |
| 168 |
RENAL FAILURE |
1 |
| 169 |
RHINITIS |
1 |
| 170 |
SINUS DISORDER |
1 |
| 171 |
SKIN LESION |
1 |
| 172 |
SKIN WOUND |
1 |
| 173 |
SPINAL OSTEOARTHRITIS |
1 |
| 174 |
THROMBOCYTOPENIA |
1 |
| 175 |
TINNITUS |
1 |
| 176 |
TREMOR |
1 |
| 177 |
TUMOUR NECROSIS |
1 |
| 178 |
URINARY INCONTINENCE |
1 |
| 179 |
URINARY TRACT INFECTION |
1 |
| 180 |
URINE PROTEIN/CREATININE RATIO DECREASED |
1 |
| 181 |
URINE PROTEIN/CREATININE RATIO INCREASED |
1 |
| 182 |
VAGINAL HAEMORRHAGE |
1 |
| 183 |
VASCULITIS |
1 |
| 184 |
VISION BLURRED |
1 |
| 185 |
WEIGHT DECREASED |
1 |
| 186 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
| 187 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |